Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01811147 · ClinicalTrials.gov registry record · Phase 4
Differentiating Unipolar and Bipolar Depression in Young Adults Using fMRI
A Phase 4 study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 192
- Enrollment target
NCT01811147 is a Phase 4 study that has completed, run by The Cleveland Clinic. The registered enrollment target is 192 participants.
The verdict
NCT01811147, a Phase 4 study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 192 participants
- Enrollment target
Study Summary
The purpose of the study is to find out what parts of the brain have increased or decreased activity and connectivity in individuals who have bipolar disorder, major depression, or no history of mood disorder. Another purpose of this study is to use MRI images to determine which young adults with major depression may be at greater risk for developing mild or more severe symptoms of mania which suggests a diagnosis of bipolar disorder.
Interventions
- DRUG Selective Serotonin Reuptake Inhibitor (SSRI)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 192 participants |
| Start Date | 2011-11 |
| Est. Completion | 2018-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01811147
The ClinicalTrials.gov registry entry for NCT01811147 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 192 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Selective Serotonin Reuptake Inhibitor (SSRI) is the first listed.
NCT01811147 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01811147 about?
NCT01811147 is a clinical study titled "Differentiating Unipolar and Bipolar Depression in Young Adults Using fMRI". The purpose of the study is to find out what parts of the brain have increased or decreased activity and connectivity in individuals who have bipolar disorder, major depression, or no history of mood disorder. Another purpose of this study is to use MRI images to determine which young adults with ma...
What is the current status of trial NCT01811147?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 192 participants. The study started on 2011-11. Estimated completion is 2018-06.
What interventions are being tested in trial NCT01811147?
The interventions under investigation include: Selective Serotonin Reuptake Inhibitor (SSRI) (DRUG).
Who is sponsoring clinical trial NCT01811147?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.